Prognostic nutritional index is an independent prognostic factor for treatment response, survival and drug choice in metastatic castration-resistant prostate cancer treated with abiraterone acetate or enzalutamide
Ahmet Küçükarda, Ali Gökyer, İvo Gökmen, Erkan Özcan, Muhammet Bekir Hacıoğlu, Bülent Erdoğan, Sernaz Uzunoğlu, İ. Çiçin
Topics & Concepts
EnzalutamideAbiraterone acetateMedicineProstate cancerInternal medicineOncologyUrologyCancerAndrogen deprivation therapyAndrogen receptorInflammatory Biomarkers in Disease PrognosisProstate Cancer Diagnosis and TreatmentHepatocellular Carcinoma Treatment and Prognosis